Convergent Therapeutics

Website

Market Activity

Secondary market transactions and available listings

Current Price

N/A

Valuation

$280M

Active Listings

Transactions

Recent Transactions

Access recent transactions and pricing history

Watch Convergent Therapeutics

Get alerts for price changes and funding rounds

Explore More Data

Detailed analysis for Convergent Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Convergent Therapeutics Secondary Market Overview

Convergent Therapeutics shares are available for trading on the secondary market through Premier Alternatives., Convergent Therapeutics has raised $130M in funding and is currently valued at $280M.

How to Buy Convergent Therapeutics Shares

Accredited investors can purchase Convergent Therapeutics shares through the secondary market:

Verify your accredited investor status
Browse available listings from existing shareholders
Submit an inquiry to the seller
Complete the transaction through our broker-dealer partner

Market Activity FAQs

What is the current Convergent Therapeutics share price?

How liquid are Convergent Therapeutics shares?

Transaction data for Convergent Therapeutics is limited.